• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (56548964)   Find a Category (125)   Find a Journal (7901)   Find a Contributing Scholar (3706)   Find an Academic Assistant (52)
Find an Article PDF (4698279)   Today's Articles (0)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
Year Published
Show more   Refine
Article Type
Show more   Refine
Article Statistics
Refine
Publication Titles
Show more   Refine
For: Hochmair MJ, Prosch H, Krenbek D, Weinlinger C, Fabikan H, Valipour A. Alectinib following brigatinib: an efficient sequence for the treatment of advanced anaplastic lymphoma kinase-positive lung cancer patients. Anticancer Drugs 2021;32:105-10. [PMID: 32868645 DOI: 10.1097/CAD.0000000000000989] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Number Cited by Other Article(s)
1
TABBÒ F, DE FILIPPIS M, JACOBS F, NOVELLO S. Strengths and pitfalls of brigatinib in non-small cell lung cancer patients' management. Minerva Med 2022;113:315-332. [DOI: 10.23736/s0026-4806.21.07693-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA